Position in INCY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$71,967,956
+$20,236,499 QoQ
Shares Held
634,862
+15.5% QoQ
Ownership
0.318%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#49
of 854 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in INCY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MACKENZIE FINANCIAL CORP holds $498,673,295 across 59 Biotechnology names. INCY ranks #2 (14.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
135,783 | $84,666,131 | |
| 2 | INCY |
Incyte Corp
This page
|
634,862 | $71,967,956 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
931,864 | $53,321,258 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
102,928 | $51,127,425 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
298,440 | $22,227,811 | |
| 6 | TBPH |
Theravance Biopharma, Inc.
|
985,848 | $16,759,416 | |
| 7 | RPRX |
Royalty Pharma plc
|
270,457 | $15,164,523 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
43,988 | $13,241,707 |
All Filings in INCY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $71,967,956 | 634,862 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $51,731,457 | 549,633 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $40,531,454 | 410,362 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $38,430,718 | 453,139 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $24,667,794 | 362,229 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $20,591,420 | 340,073 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $16,717,357 | 242,035 | Shares | Sole | 2025-05-02 | |
| 2024-09-30 | $17,190,825 | 260,073 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $23,138,896 | 381,704 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $22,435,868 | 393,819 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $23,470,211 | 373,789 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $18,960,749 | 328,211 | Shares | Sole | 2023-10-25 | |
| 2023-06-30 | $18,454,697 | 296,461 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $17,548,601 | 242,820 | Shares | Sole | 2023-04-24 | |
| 2022-12-31 | $19,391,496 | 241,428 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $12,318,004 | 184,844 | Shares | Sole | 2022-10-07 | |
| 2022-06-30 | $12,000,525 | 157,964 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $9,408,410 | 118,464 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $3,783,256 | 51,543 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,800,102 | 40,711 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $2,956,664 | 35,144 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $2,341,388 | 28,810 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $2,617,489 | 30,093 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $2,020,585 | 22,516 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $2,856,575 | 27,475 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $1,313,453 | 17,936 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||